Explore our tests
Discover the right genetic test for your patient in our complete list of tests and panels.
Showing 10 out of 402 tests
NavigATTR Sponsored Testing Program
Sponsored TestNGS with CNV (Exome or Genome Platform)
2 - 3 weeks•Test 15139
2 - 3 weeks•Test 151391 Gene
Nemaline Myopathy (NEM2) via the Nebulin (NEB) Gene
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 1772
2 - 3 weeks (7 - 16 days STAT)•Test 17721 Gene
Nemaline Myopathy via the NEB Exon 55 Deletion
Targeted PCR2 - 3 weeks (8 - 10 days STAT)•Test 356
2 - 3 weeks (8 - 10 days STAT)•Test 3561 Gene
Nemaline Myopathy via the NEB Gene, Exons 82-105 (Triplicate Repeat Region)
Sanger Sequencing3 - 4 weeks (12 - 19 days STAT)•Test 2079
3 - 4 weeks (12 - 19 days STAT)•Test 20791 Gene
Neonatal Respiratory Distress Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 13349
2 - 3 weeks (6 - 12 days STAT)•Test 133495 Genes
Nephrolithiasis and Nephrocalcinosis Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (6 - 12 days STAT)•Test 10395
2 - 3 weeks (6 - 12 days STAT)•Test 1039530 Genes
Nephrotic Syndrome (NS)/Focal Segmental Glomerulosclerosis (FSGS) Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 10417
2 - 3 weeks (7 - 16 days STAT)•Test 1041772 Genes
Neuroblastoma Panel
NGS with CNV (PGselect Platform)2 - 3 weeks (7 - 16 days STAT)•Test 5057
2 - 3 weeks (7 - 16 days STAT)•Test 505715 Genes
Neurodegeneration with Brain Iron Accumulation Panel
NGS with CNV (Exome or Genome Platform)2 - 3 weeks (7 - 16 days STAT)•Test 2695
2 - 3 weeks (7 - 16 days STAT)•Test 269516 Genes
Neurofibromatosis Type 1 (NF1) and Legius Syndrome Panel
NGS with CNV (PGselect Platform)2 - 3 weeks (7 - 16 days STAT)•Test 10099
2 - 3 weeks (7 - 16 days STAT)•Test 100992 Genes